Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trialRandomized Controlled Trial Published on 2023-03-012023-07-11 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2022.12.028 PMC 바로가기 [Article Type] Randomized Controlled Trial
Morning SARS-CoV-2 Testing Yields Better Detection of Infection Due to Higher Viral Loads in Saliva and Nasal Swabs upon WakingArticle Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] [DOI] 10.1128/spectrum.03873-22 PMC 바로가기
SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2Article Published on 2022-12-012022-11-16 Journal: Journal of medical virology [Category] [DOI] 10.1002/jmv.28079 PMC 바로가기
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trialClinical Trial Published on 2022-12-012023-07-10 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2022.104322 PMC 바로가기 [Article Type] Clinical Trial
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022Article Published on 2022-11-012023-07-11 Journal: Influenza and Other Respiratory Viruses [Category] [DOI] 10.1111/irv.13029 PMC 바로가기
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sourcesArticle Published on 2022-10-292022-11-15 Journal: Nature Communications [Category] [DOI] 10.1038/s41467-022-33864-y PMC 바로가기
Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 – United States, January-July 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] [DOI] 10.15585/mmwr.mm7143a2 PMC 바로가기
Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 OutpatientsArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] [DOI] 10.1128/spectrum.01682-22 PMC 바로가기
Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric studyArticle Published on 2022-10-212022-11-15 Journal: Medicine [Category] [DOI] 10.1097/MD.0000000000031288 PMC 바로가기
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19Article Published on 2022-10-192022-11-15 Journal: PLoS Medicine [Category] [DOI] 10.1371/journal.pmed.1004120 PMC 바로가기